Back to Journals » ClinicoEconomics and Outcomes Research » Volume 14

Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds

Total article views   HTML views PDF downloads Totals
7,135 Dovepress* 6,650+ 460 7,110
PubMed Central* 485 106 591
Totals 7,135 566 7,701
*Since 2 May 2022
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 2 4

View citations on PubMed Central and Google Scholar